CUSIP 70261F202COM NEWKTTAQ4 2025
17 filings · latest Feb 27, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 2.10M | $2.72M |
| 2 | Squadron Capital Management LLC | 2.10M | $2.71M |
| 3 | Vivo Capital, LLC | 2.10M | $2.71M |
| 4 | Adage Capital Partners Gp, L.L.C. | 2.10M | $2.71M |
| 5 | Ameriprise Financial Inc | 1.93M | $2.49M |
| 6 | Cable Car Capital, LP | 500.0K | $645.0K |
| 7 | Acuta Capital Partners, LLC | 450.0K | $580.5K |
| 8 | Stempoint Capital LP | 355.1K | $458.1K |
| 9 |
| 4 | Feb 17, 2026 | Ameriprise Financial, Inc. | 13G | 8.4% | 1.93M | SEC |
| 5 | Feb 12, 2026 | Adage Capital Management, L.P. | 13G | 10.0% | 2.33M | SEC |
| 6 | Dec 8, 2025 | Janus Henderson Group PLC | 13G | 10.0% | 10.23M | SEC |
| 7 | Dec 5, 2025 | Squadron Master Fund LP | 13G | 9.9% | 2.25M | SEC |
| 8 | Dec 5, 2025 | Vivo Opportunity Fund Holdings, L.P. | 13G | 10.0% | 17.56M | SEC |
| 9 | Aug 14, 2025 | Cvi Investments, Inc. | 13G/A | 9.9% | 826.1K | SEC |
| 10 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 5.0% | 142.1K | SEC |
See the full Schedule 13D/13G history for Pasithea Therapeutics Corp.
Unlock full history| Advisorshares Investments LLC |
| 304.7K |
| $393.1K |
| 10 | Persistent Asset Partners Ltd | 290.6K | $374.8K |